![Barbara Leyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Leyman
Plus aucun poste en cours
Fortune : 46 943 $ au 31/05/2026
Profil
Barbara Leyman worked as Senior Investment Manager at Limburgse Reconversie Maatschappij NV from 2014 to 2017.
Former jobs include Non-Executive Director at Apitope International NV, Director at Amakem NV, Director at Complix NV, Chief Business Development Officer at Sutro Biopharma, Inc. from 2024 to 2025, and Senior Vice President-Corporate Development at Breeze Bio, Inc. Education includes a doctorate from Imperial College London and a graduate degree from Ghent University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/07/2025 | 1 606 ( 0,01% ) | 46 943 $ | 31/05/2026 |
Anciens postes connus de Barbara Leyman
| Sociétés | Poste | Fin |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2025 |
Limburgse Reconversie Maatschappij NV
 Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Private Equity Investor | 01/07/2017 |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Corporate Officer/Principal | - |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Directeur/Membre du Conseil | - |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Directeur/Membre du Conseil | - |
Formation de Barbara Leyman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limburgse Reconversie Maatschappij NV
Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Finance |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Health Technology |
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
